Octreotide and Lanretotide for Neuroendocrine Tumors: What You Need to Know

Discover how somatostatin analogues like octreotide and lanreotide manage neuroendocrine tumors (NETs) by controlling symptoms and slowing growth. This guide covers their mechanisms, landmark trials like PROMID and CLARINET, dosing, side effects, monitoring, and practical steps for patients and families. Ideal for those with NETs seeking evidence-based insights on SSA therapy. 00:00 Introduction 00:45 What Are Somatostatin Analogues? 01:15 How SSAs Work - Dual Benefits 02:30 Trial Evidence: PROMID and CLARINET 03:50 Dosing Details That Matter 04:45 Side Effects - Honest Expectations 05:35 Monitoring to Stay on Track 06:10 Action Steps: What You Can Do This content is entirely based on medical research and evidence, carefully curated by Mr Saboor Khan PhD FRCS FACS (Consultant Surgeon). Explore the full video series for a broader understanding of your condition with evidence-based content—check out the playlist for comprehensive NET management. Educational Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Personal medical decisions must be made in consultation with your treating healthcare team. Patients should not draw inferences about their own condition from this material. Every effort has been made to ensure the content is current at the time of production; however, this cannot be guaranteed.